Provided by Tiger Fintech (Singapore) Pte. Ltd.

COSMOS HEALTH INC

0.4750
+0.01703.71%
Post-market: 0.47500.00000.00%19:00 EDT
Volume:298.46K
Turnover:138.79K
Market Cap:13.62M
PE:-0.48
High:0.4780
Open:0.4616
Low:0.4501
Close:0.4580
Loading ...

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

GlobeNewswire
·
01 May

INOVIO to Present at Upcoming Scientific and Investor Conferences

PR Newswire
·
30 Apr

Grigorios Siokas, CEO, Reports Acquisition of Common Shares in Cosmos Health Inc

Reuters
·
28 Apr

Cosmos Health Reports FY24 Revenue $54.34M Up From $53.38M YoY

Benzinga
·
17 Apr

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

GlobeNewswire
·
10 Apr

Cosmos Health launches Sky Premium Life in Albania, secures $300,000 order

TIPRANKS
·
08 Apr

Cosmos Health Launches Sky Premium Life in Albania Through Partnership With Pharma Cell; Secures Initial $300,000 Order

THOMSON REUTERS
·
08 Apr

Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order

GlobeNewswire
·
08 Apr

Cosmos Health Inc. (NASDAQ:COSM) Might Not Be As Mispriced As It Looks After Plunging 31%

Simply Wall St.
·
04 Mar

Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates

ACCESS Newswire
·
27 Feb

EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency

Benzinga
·
25 Feb

Bullish Cosmos Health Insiders Loaded Up On US$539.0k Of Stock

Simply Wall St.
·
20 Feb

BRIEF-Cosmos Health Announces It Will Not Proceed With An Offering Under Its Form S-1

Reuters
·
19 Feb

Cosmos Health Announces It Will Not Proceed With an Offering Under Its Form S-1

THOMSON REUTERS
·
19 Feb

Cosmos Health will not proceed with offering under Form S-1

TIPRANKS
·
18 Feb

Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1

ACCESS Newswire
·
18 Feb

Cosmos enters final development phase of CCX0722 weight managment solution

TIPRANKS
·
11 Feb

Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market

ACCESS Newswire
·
11 Feb

Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market

ACCESS Newswire
·
11 Feb

Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

ACCESS Newswire
·
10 Feb